MDRX Volume Alert - MDRX 11.15 Allscripts Healthcare

New Post Public Reply Private Reply Replies (0) Message Board
leahanne
MDRX Volume Alert - MDRX 11.15 Allscripts Healthcare Solutions $MDRX Hit a high of 11.32 Currently 11:15 Last price 11.15 -0.13 -1.15% With a day low of 11.13 and a current volume of 3,199,391.

MDRX Allscripts Healthcare Solutions Recent Headline News

Catholic Health Initiatives chooses Allscripts Remote Hosting Solution
PR Newswire - Tue Nov 11, 7:01AM CST
Allscripts (NASDAQ:MDRX) has announced that Catholic Health Initiatives (CHI), one of the largest health systems in the nation, has selected Allscripts Hosting Solution to provide enterprise-wide information technology (IT) through 2020.
MDRX: 11.14 (-0.14)

Nasdaq stocks posting largest percentage decreases
AP - Fri Nov 07, 5:08PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
TNGO: 12.82 (+0.42), PRSC: 38.22 (+0.34), FNGN: 31.12 (-0.23), LACO: 7.00 (+0.06), MSON: 11.55 (unch), SLXP: 97.15 (+3.28), FNHC: 26.04 (-0.91), MDRX: 11.14 (-0.14), PCMI: 8.68 (-0.12), UBNT: 28.30 (-0.90), PFMT: 6.65 (-0.09), ICPT: 173.25 (-3.10), ANDE: 54.36 (-0.41), ACTA: 17.14 (+0.19)

Allscripts Healthcare Solutions Set to Possibly Rebound After Yesterday's Selloff of 14.83%
Comtex SmarTrend(R) - Fri Nov 07, 3:57PM CST
Allscripts Healthcare Solutions (NASDAQ:MDRX) traded in a range yesterday that spanned from a low of $11.00 to a high of $11.76. Yesterday, the shares fell 14.8%, which took the trading range below the 3-day low of $13.40 on volume of 16.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
MDRX: 11.14 (-0.14)

Allscripts Healthcare Q3 Earnings, Revenues Miss Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 12:30PM CST
Allscripts Healthcare Solutions, Inc. (MDRX) posted adjusted earnings of 2 cents per share in the third quarter of 2014 which missed the Zacks Consensus Estimate by 3 cents.
GWPH: 74.60 (+0.65), ABAX: 53.36 (+0.42), MDRX: 11.14 (-0.14), MRGE: 3.15 (-0.03)

Allscripts Healthcare Solutions (MDRX) Stock Lower After Earnings Miss
at The Street - Fri Nov 07, 9:20AM CST
Allscripts Healthcare Solutions (MDRX) is falling Friday after missing analysts' estimates for earnings and revenue in the third quarter.
MDRX: 11.14 (-0.14)

Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 8:14AM CST

BEBE: 2.40 (+0.02), ANET: 76.15 (-0.64), TKMR: 16.16 (-0.32), ORBC: 6.30 (+0.23), MDRX: 11.14 (-0.14), RMTI: 11.14 (+0.24), CTIC: 2.18 (+0.04), SHLD: 37.89 (-0.83), UBNT: 28.30 (-0.90), RIG: 28.72 (-0.56), KGC: 2.42 (+0.08), APT: 3.02 (-0.09), ANF: 28.86 (+0.17), MITK: 3.28 (+0.13), ZNGA: 2.62 (+0.14), CNET: 2.13 (-0.02), KING: 13.79 (+0.05), NETE: 1.50 (+0.01), SLXP: 97.15 (+3.28), RPRX: 9.13 (-0.09), NADL: 5.00 (-0.12), PGNX: 6.51 (+0.54), AVNR: 13.42 (+0.20), FSLR: 51.27 (-0.69), DVA: 74.96 (+0.24), NDLS: 24.16 (-0.41), ICPT: 173.25 (-3.10), AGIO: 84.01 (+2.23), PLNR: 6.76 (-0.92)

Allscripts -19.2% on Q3 miss, bookings drop
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 8:01AM CST

MDRX: 11.14 (-0.14)

Allscripts Healthcare Solutions' (MDRX) CEO Paul Black on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 06, 10:20PM CST

MDRX: 11.14 (-0.14)

AllScripts Healthcare reports 3Q loss
AP - Thu Nov 06, 5:44PM CST
CHICAGO (AP) — Allscripts Healthcare Solutions Inc. on Thursday posted lower-than-expected third-quarter results and the stock of the electronic health records company tumbled in extended trading.
MDRX: 11.14 (-0.14)

After Hour Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 4:36PM CST

YUME: 4.73 (-0.06), UBNT: 28.30 (-0.90), APT: 3.02 (-0.09), ECOM: 18.52 (+0.18), KTOS: 5.43 (-0.06), SLXP: 97.15 (+3.28), MRC: 21.04 (+0.40), MDRX: 11.14 (-0.14), SSE: 11.52 (-0.59), NKTR: 13.99 (+0.20)

Allscripts Healthcare Solutions (MDRX) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Nov 06, 3:25PM CST

MDRX: 11.14 (-0.14)

Allscripts Healthcare Solutions misses by $0.04, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 3:04PM CST

MDRX: 11.14 (-0.14)

Allscripts announces third quarter 2014 results
PR Newswire - Thu Nov 06, 3:01PM CST
Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX) ("Allscripts" today announced its financial results for the three and nine months ended September 30, 2014.
MDRX: 11.14 (-0.14)

Downtrend Call Working As Allscripts Healthcare Solutions Stock Falls 12.9% (MDRX)
Comtex SmarTrend(R) - Thu Nov 06, 9:33AM CST
SmarTrend identified a Downtrend for Allscripts Healthcare Solutions (NASDAQ:MDRX) on August 4th, 2014 at $15.49. In approximately 3 months, Allscripts Healthcare Solutions has returned 12.92% as of today's recent price of $13.49.
MDRX: 11.14 (-0.14)

Etransmedia Wins Multi-Million Dollar Award against Allscripts Healthcare in High-Profile Deceptive Business Practice Case
GlobeNewswire - Thu Nov 06, 4:56AM CST
After a hard-fought trial, Etransmedia Technology, Inc. won a decisive victory when an arbitration panel in Raleigh, North Carolina ruled that Allscripts Healthcare, LLC (NASDAQ: MDRX), with offices in Chicago, and Raleigh, NC, had breached its partner agreement with Etransmedia, and violated the North Carolina Unfair and Deceptive Trade Practices Act.
MDRX: 11.14 (-0.14)

Allscripts Healthcare: Blue Harbour Group Won't Go Lightly
Marshall Hargrave - at Seeking Alpha - Wed Nov 05, 12:39PM CST

MDRX: 11.14 (-0.14), CERN: 63.22 (-0.20), ATHN: 121.44 (-2.04)

Allscripts launches new mobile acute care solution
M2 - Thu Oct 30, 7:37AM CDT
Allscripts (NASDAQ: MDRX) said it has introduced Sunrise Mobile Care, a new mobile application for the Allscripts Sunrise EHR that delivers valuable medication, order and result information to the mobile devices of nurses and other clinicians.
MDRX: 11.14 (-0.14)

Allscripts launches new mobile acute care solution designed for nursing professionals
CNW Group - Wed Oct 29, 7:01AM CDT
Allscripts (NASDAQ: MDRX) has introduced Sunrise Mobile CareTM, a new mobile application for the Allscripts Sunrise EHR that delivers valuable medication, order and result information to the mobile devices of nurses and other clinicians.
MDRX: 11.14 (-0.14)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 159

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 92

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 118

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 158

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 98

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 0

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 201

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 0

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading

Top 5 Most Recently Viewed Articles

Jeff McLean Takes the Helm as ghSMART's New CEO

Updated Category News Views 620

Jeff McLean Takes the Helm as ghSMART's New CEO G.H. Smart & Company, LLC, the leading firm in leadership advisory, proudly announces the appointment of Jeff McLean as the Chief Executive Officer. McLean, who has been serving as President of ghSMART for three years, will now guide the firm towards its next exciting phase of growth and innovation. Achievements Under...

Continue Reading
Growth Forecast for Hot Dog and Sausage Market to 2032

Updated Category News Views 51

Introduction to the Hot Dog and Sausage Market The global market for hot dogs and sausages is witnessing a remarkable upward trajectory, with projections estimating it will reach USD 112.41 billion by 2032. This growth is fueled by a compound annual growth rate (CAGR) of 3.50%. The factors contributing to this expansion are numerous, including shifting consumer...

Continue Reading
Exro Technologies Adjusts Leadership with New CEO Plans

Updated Category News Views 337

Exro Technologies Announces Leadership Changes Exro Technologies Inc. has made a significant announcement regarding its leadership structure. Following the resignation of Sue Ozdemir from her role as Chief Executive Officer, the company has initiated steps to ensure a seamless transition and continuity in leadership. New Chief Restructuring Officer Appointed Introduction...

Continue Reading
Hillenbrand Increases Quarterly Dividend to $0.225 Per Share

Updated Category News Views 208

Hillenbrand's Exciting Dividend Announcement The board of directors of Hillenbrand, Inc. (NYSE: HI) has proudly announced a regular cash dividend of $0.225 per share on its common stock. This announcement signifies an annual increase of $0.01, bringing the total dividend rate to $0.90 per share for fiscal 2025. Such a commitment underlines Hillenbrand's dedication to...

Continue Reading
Trump's World Liberty Financial Token Sale Raises $220 Million

Updated Category News Views 113

Trump's World Liberty Financial Token Sale Demonstrates Huge Demand The World Liberty Financial project, closely associated with Donald Trump, made headlines recently as its token sale reached an impressive $220 million in just the first hour. Despite facing multiple outages on its website, the initiative showcased remarkable demand and interest. Details of the Token Sale...

Continue Reading